SCHEMBL4556281

SCHEMBL4556281

Cc1nccc(-c2ncnc3c2CNC3)c1C

nearest known ligand 0.40

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.40
GRM4 Q14833 1/20 0.31
TLR9 Q9NR96 2/20 0.30
TLR8 Q9NR97 2/20 0.30
TLR7 Q9NYK1 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4556280 0.78 CYP1A2 (0.38) CYP1A2
SCHEMBL28970115 0.73 AURKB (0.46)
SCHEMBL25625850 0.67 HTR2A (0.36) CYP1A2
Hydrochloric Acid SCHEMBL31644306 0.65 HTR2A (0.35) CYP1A2
SCHEMBL18599128 0.63 CYP1A2 (0.31) CYP1A2
SCHEMBL3411218 0.63 CYP2A6 (0.32) CYP1A2
SCHEMBL30775181 0.62 CCNC (0.36) CYP1A2GRM4
SCHEMBL25678467 0.62 CYP1A2 (0.36) CYP1A2
SCHEMBL30775411 0.62 PRCP (0.44) CYP1A2GRM4
SCHEMBL19357887 0.61 CYP1A2 (0.35) CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2125757-A1 MACROCYCLIC COMPOUNDS AS HCV NS3 PROTEASE INHIBITORS Novartis AG (CH) 2009-12-02 EP disclosed
WO-2008101665-A1 MACROCYCLIC COMPOUNDS AS HCV NS3 PROTEASE INHIBITORS NOVARTIS AG (CH) 2008-08-28 WO disclosed